Article Information
History
- June 9, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Benjamin Rossi1,*,#,
- Lee S. Nguyen2,3,#,
- Philippe Zimmermann4,
- Faiza Boucenna1,
- Louis Dubret4,
- Louise Baucher1,
- Helene Guillot1,
- Marie-Anne Bouldouyre1,
- Yves Allenbach5,
- Joe-Elie Salem3,
- Paul Barsoum6,
- Arezki Oufella4 and
- Helene Gros1
- 1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
- 2Research & innovation of CMC Ambroise Paré, 92200 Neuilly-sur-Seine, France
- 3Sorbonne Université, INSERM, Clinical Investigations Center Paris-Est, CIC-1901, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
- 4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
- 5Sorbonne Université, Department of Internal medicine and Clinical Immunology, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
- 6Department of cardiology, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
- ↵#Corresponding author
Dr Benjamin Rossi, Department of internal medicine, 93600 Aulnay-sous-bois, France, tèl: +33149367021; +33149367199; benjamin.rossi{at}ght-gpne.fr
↵* these authors equally contributed to the manuscript
Posted June 09, 2020.
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
